The use of OpdA in rat models of organic phosphorus (OP) poisoning.
Bretholz
Adam
A
Morrisey
Ryan
R
Hoffman
Robert S
RS
D000818:Animals; D043303:Aryldialkylphosphatase / Q000627:therapeutic use*; D001285:Atropine / Q000627:therapeutic use; D001426:Bacterial Proteins / Q000627:therapeutic use*; D002801:Cholinesterase Reactivators / Q000627:therapeutic use*; D004357:Drug Synergism; D062025:Organophosphate Poisoning; D010275:Parasympathetic Nervous System / Q000473:pathology; D011220:Pralidoxime Compounds / Q000494:pharmacology; D051381:Rats; D013569:Synapses / Q000473:pathology
D001426:Bacterial Proteins; D002801:Cholinesterase Reactivators; D011220:Pralidoxime Compounds; D001285:Atropine; D043303:Aryldialkylphosphatase; C028797:pralidoxime